Login to Your Account

Following CF Failure, Inspire Focuses on Eye-Care Business

By Catherine Shaffer

Friday, February 18, 2011
Inspire Pharmaceuticals Inc. is mothballing its cystic fibrosis program and regrouping as an eye-care company after Phase III trials of denufosol tetrasodium ended in disappointment.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription